Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s One Insider Who is Bullish on Wendy’s Co (WEN)

Wednesday morning’s SEC Form 4 filings detail the insider transactions of A. Scott Weisberg, the Chief People Officer at Wendy’s Co. (NASDAQ:WEN). On this date, September 5th, Mr. Weisberg purchased 20,000 shares of WEN worth more than $80,000. The buys, which were made at an average purchase price of $4.32, increased Mr. Weisberg’s total holdings in his company by a factor of sixty. Before the move, his holdings totaled just 400 shares. These transactions come with curious timing, as the company is coming off of a rather unexciting earnings report last quarter.

The Wendy's Co (NASDAQ:WEN)

In fact, since the start of 2012, shares of Wendy’s have lost 19.4%, falling flatter than culinary competitors like McDonald’s (NYSE:MCD) at -11.2%, Yum Brands (NYSE:YUM) at 6.7%, Jack In The Box (NASDAQ:JACK) at 26.8%, and Sonic (NASDAQ:SONC) at 46.5%. While the bears typically blame a sluggish economic recovery for this selloff, Wendy’s woes are more a result of its determination to shift its focus toward premium products, á la Hardee’s. Over the past few months, the fast food chain has begun testing items like “Black Label Burgers,” and various upscale salad options.

Thus far, results have been mixed. The company disappointed investors in its second quarter earnings release last month, where it posted a loss of $5.5 million, compared to a profit of $11.3 million in Q2 of 2011. Now, adjusted earnings did meet the Street’s expectations at $0.05 a share, but quarterly revenues ($645.9M) missed targets ($647.0M). Interestingly, the stock was up over 4.0% in after-hours trading on Tuesday, riding news that Zacks Investment Research had reaffirmed its neutral rating. The report cited that the company’s strengths lie in its “multiyear turnaround plan,” and its “new breakfast menu and traction to late-night [customers].”

When valuing the company’s earnings, shares of WEN aren’t the most attractive investment, as they are currently trading at a Forward Price-to-Earnings ratio (23.2X) above the likes of MCD (14.9X), YUM (16.9X), JACK (16.6X), and SONC (14.4X). Moreover, the stock sports a stratospheric PEG ratio of 2.7; typically any figure above 2.0 signals an overvaluation.

Intriguingly, Wendy’s looks a bit better from a Price-to-Book (0.9X) and Price-to-Sales (0.7X) standpoint, as both of these metrics are trading below the industry norms of 6.1X and 2.1X respectively. When compared to 5-year average P/B ratios, the company is trading at a 19% discount in relation to its historical book value. This discount is greater than MCD (+18%), YUM (+185%), and JACK (+8%), which are trading at premiums over their historical book values.

Now, some players in the hedge fund industry do like this stock, including Nelson Peltz, Boaz Weinstein, and Israel Englander. Peltz’s Trian Partners fund holds nearly $400 million worth of WEN, amounting to 12.6% of the manager’s total 13F holdings. More prominent managers who are bullish on Wendy’s include D.E. Shaw and Steven Cohen, though each fund’s commitment to the stock is worth less than 0.1% of total holdings. As noted in our top ten list of the 10 Most Popular Restaurant Stocks Among Hedge Funds, Yum Brands and McDonald’s are preferred investments over Wendy’s, likely due to their more reasonable earnings valuations.

To recap: Wendy’s stock has been beaten down in 2012, as revenues and earnings have been quite mediocre. The company does have a turnaround plan in place, and the Street expects improvements in EPS by the end of next year. From a valuation standpoint, WEN is a mixed bag, though Price-to-Book Value ratios are encouraging. Throw in the fact that one insider in particular has been behaving very bullishly, and there are a few reasons to like this stock.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!